ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

RSLS ReShape Lifesciences Inc

0.1743
-0.0037 (-2.08%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 318,279
Bid Price 0.1694
Ask Price 0.20
News -
Day High 0.1834

Low
0.1414

52 Week Range

High
2.798

Day Low 0.167
Share Name Share Symbol Market Stock Type
ReShape Lifesciences Inc RSLS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0037 -2.08% 0.1743 23:00:07
Open Price Low Price High Price Close Price Previous Close
0.174 0.167 0.1834 0.1698 0.178
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
548 318,279 US$ 0.1769185 US$ 56,309 - 0.1414 - 2.798
Last Trade Type Quantity Price Currency
17:39:03 2 US$ 0.1735 USD

ReShape Lifesciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.99M 23.46M - 8.68M -11.39M -0.49 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ReShape Lifesciences News

Date Time Source News Article
4/01/202415:05GlobeNewswire Inc.ReShape Lifesciences® Reports Year Ended December 31, 2023..
3/28/202407:31GlobeNewswire Inc.ReShape Lifesciences® Receives Notice of Allowance for..
3/04/202407:31GlobeNewswire Inc.ReShape Lifesciences® Provides Update on 2024 Cost Reduction..
2/26/202415:19Edgar (US Regulatory)Form 8-K - Current report
2/22/202407:31GlobeNewswire Inc.ReShape Lifesciences® Announces First Surgeries Utilizing..
1/24/202407:31GlobeNewswire Inc.ReShape Lifesciences® Conducts Bariatric Fellows Training..
1/18/202415:38Edgar (US Regulatory)Form 8-K - Current report
1/16/202417:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
1/05/202415:14Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statements
12/20/202307:31GlobeNewswire Inc.ReShape Lifesciences® Engages Maxim Group LLC To Identify..
12/12/202315:05GlobeNewswire Inc.ReShape Lifesciences® Receives FDA PMA Supplement Approval..
11/29/202315:05Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RSLS Message Board. Create One! See More Posts on RSLS Message Board See More Message Board Posts

Historical RSLS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.17180.18340.16510.1709023130,9900.00251.46%
1 Month0.16210.2090.1580.1696797306,3770.01227.53%
3 Months0.20010.22450.14140.1715725503,914-0.0258-12.89%
6 Months0.22770.590.14140.32423383,032,071-0.0534-23.45%
1 Year2.472.7980.14140.34664542,271,377-2.30-92.94%
3 Years475.00475.000.141476.031,504,408-474.83-99.96%
5 Years475.00475.000.141476.031,504,408-474.83-99.96%

ReShape Lifesciences Description

Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app.

Your Recent History

Delayed Upgrade Clock